FLT3 in human hematologic malignancies

Leukemia and Lymphoma

Volumn 43, Issue 8, 2002, Pages 1541-1547

  Kiyoi, Hitoshi ^a   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

FLT3; Leukemia; Molecular target; Mutations; Receptor tyrosine kinase

Indexed keywords

6,7 DIMETHYL 2 PHENYLQUINOXALINE; ASPARTIC ACID; CD33 ANTIGEN; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 90; HERBIMYCIN A; IMATINIB; MICROSOMAL AMINOPEPTIDASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID; SINGLE STRANDED DNA; STEM CELL FACTOR; TYROSINE; VALINE; BENZOQUINONE DERIVATIVE; CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; HERBIMYCIN; MACROCYCLIC LACTAM; ONCOPROTEIN; QUINONE DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; B CELL LEUKEMIA; BLOOD DISEASE; BRAIN CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; FREQUENCY ANALYSIS; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DISORDER; GENETIC PREDISPOSITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; LEUKOCYTOSIS; LIVER CELL; MISSENSE MUTATION; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TANDEM REPEAT; DRUG ANTAGONISM; GENETICS; MUTATION; REVIEW;

HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; MUTATION; PROTO-ONCOGENE PROTEINS; QUINONES; RECEPTOR PROTEIN-TYROSINE KINASES; TANDEM REPEAT SEQUENCES; BENZOQUINONES; FMS-LIKE TYROSINE KINASE 3; HUMANS; LACTAMS, MACROCYCLIC;

EID: 0036020954     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000002866     Document Type: Article

References (63)

1. "Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family"
2. "Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells"
3. "Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene"
4. "A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations"
5. "RTK mutations and human syndromes: When good receptors turn bad"
6. "c-Kit and c-kit mutations in mastocytosis and other hematological diseases"
7. "Expression and signal transduction of the FLT3 tyrosine kinase receptor"
8. "Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs"
9. "Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children"
10. "The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34 + bone marrow progenitor cells in vitro"
11. "Biology of flt3 ligand and receptor"
12. "c-kit Ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities"
13. "Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines"
14. "Expression of the FLT3 gene in human leukemia-lymphoma cell lines"
15. "Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells"
16. "Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells"
17. "Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells"
18. "Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells"
19. "Internal tandem duplication of the flt3 gene found in acute myeloid leukemia"
20. "Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines"
21. "Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies"
22. "Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)"
23. "Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children"
24. "Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia."
25. "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia"
26. "Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia"
27. "Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene"
28. "FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group"
29. "Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells"
30. "The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Patients from the United Kingdom Medical Research Council AML 10 and 12 trials"
31. "FLT3, RAS and TP53 mutations in elderly patients with acute myeloid leukemia"
32. "Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study"
33. "Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia."
34. "Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia"
35. "Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia"
36. "Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product"
37. "Preferential DNA secondary structure mutagenesis in the lagging strand of replication in E. coli"
38. "Stabilization of diverged tandem repeats by mismatch repair: Evidence for deletion formation via a misaligned replication intermediate"
39. "Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product"
40. "C-kit mutations in core binding factor leukemias"
41. "Switching signals on or off by receptor dimerization"
42. "Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation"
43. "Long-term survival of patients with acute myeloid leukemia: A third follow-up of the Fourth International workshop on chromosomes in leukemia"
44. "N-ras mutations in adult de novo acute myelogenous leukemia: Prevalence and clinical significance"
45. "Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia"
46. "Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia"
47. "P53 gene mutations in acute myeloid leukemia with 17p monosomy"
48. "The non-random distribution of point mutations in leukaemia and myelodysplasia-a possible pointer to their aetiology"
49. "p53 Mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies"
50. "Tandem duplication of the FLT3 gene is infrequent in infant acute leukemia."
51. "Molecular evolution of acute myeloid leukaemia in relapse: Unstable N-ras and FLT3 genes compared with p53 gene"
52. "In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor"
53. "Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines"
54. "Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways"
55. "Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain"
56. "FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model"
57. "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia"
58. "Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia"
59. "Hsp90 and Co.-a holding for folding"
60. "Molecular chaperones: The busy life of Hsp90"
61. "FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy"
62. "Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor"
63. "A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations"